"Tule turvallisesti paikan päälle tai asioi etänä. Varaa aika verkkosivuiltamme tai asiakaspalvelun kautta numerosta 030 6000. Ajanvaraus on auki vuorokauden ympäri. Koko Suomen kattavaa toimipaikkaverkostoa täydentävät ympäri vuorokauden saatavilla olevat digitaaliset etäpalvelut. Lääkäri-chat päivystää ilman ajanvarausta 24/7. Voit myös varata ajan video- tai puhelinvastaanotolle valitsemallesi asiantuntijalle. Nopeasti hyvään hoitoon!"

During the past decade, Terveystalo Kamppi conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Terveystalo Kamppi" #1 sponsor was "Biohit Oyj" with 2 trials, followed by "Biogen" with 1 trials sponsored, "Bone Index Finland Ltd" with 1 trials sponsored, "Eli Lilly and Company" with 1 trials sponsored and "Tampere University Hospital" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Terveystalo Kamppi" #1 collaborator was "The Finnish Funding Agency for Technology and Innovation (TEKES)" with 2 trials as a collaborator, "Merck Sharp & Dohme LLC" with 1 trials as a collaborator and "Terveystalo" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Terveystalo Kamppi" are "Alzheimer's Disease" (1 trials), "Axial Spondyloarthritis" (1 trials), "Carpal Tunnel Syndrome" (1 trials), "Cluster Headache" (1 trials) and "Migraine" (1 trials). Many other conditions were trialed in "Terveystalo Kamppi" in a lesser frequency.

Most popular intervention types in "Terveystalo Kamppi" are "Drug" (4 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Acetium" (2 trials), "Aducanumab (BIIB037)" (1 trials), "Ixekizumab" (1 trials) and "splinting" (1 trials). Other intervention names were less common.

The vast majority of trials in "Terveystalo Kamppi" are 5 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Terveystalo Kamppi". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Terveystalo Kamppi, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Terveystalo Kamppi, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".